at://
/
app.bsky.feed.post
/
3mnaowzp7s22b
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
PostEmbed
Dr Lucia Nappi speaks to ecancer at ASCO 2026 about findings from the S1823/GCC.1 study, a trial evaluating circulating miR371 as a biomarker for relapse in pat
ecancer.org
miR371 shows promise as a surveillance biomarker for relapse in early-stage germ cell tumours - ecancer
